Despite the undeniable bearish momentum, the €63.50 support is a mayor player in Sanofi. It is likely that a rebound towards at least the €68 zone occurs during the next weeks. A second likely bullish target is €71.95.
Good luck fellow traders
The has been absolutely no fundamental change to this bio company that has multiple big pharma partners. Yet due to the overall biotech downturn NASDAQ:PIRS was hit pretty hard. This presents a true 10 bagger opportunity , and Im not even remotely stretching the truth. The technicals show you why right now is the PERFECT time to buy. A little due diligence will...